Ajinomoto Bio-Pharma
Other Pharmaceuticals and Biotechnology
Ajinomoto Bio-Pharma valuation and funding history | Last updated: May 1, 2025 | 1 funding rounds
Current Valuation
N/A
As of May 1, 2025
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO (Add-on)†
$1.0B
Last Funding
May 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| May 1, 2025 | Buyout/LBO (Add-on)† | $1.0B | N/A | - |
Valuation Analysis
Current Valuation Metrics
Ajinomoto Bio-Pharma is currently valued at N/A as of May 1, 2025.
What is Ajinomoto Bio-Pharma Worth in 2026?
Ajinomoto Bio-Pharma is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Ajinomoto Bio-Pharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Ajinomoto Bio-Pharma Valuation is Determined
Private company valuations like Ajinomoto Bio-Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.